Is ibuprofen (nonsteroidal anti-inflammatory drug (NSAID)) safe for a 2-month-old infant with potential impaired renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is Ibuprofen Safe in a 2-Month-Old Infant?

No, ibuprofen is contraindicated in a 2-month-old infant and should not be used. Ibuprofen is only approved for use in children aged 3 months and older with body weight above 5-6 kg 1, 2.

Age-Specific Contraindications

  • Ibuprofen is contraindicated in neonates and infants younger than 3 months of age 3, 1.
  • The drug is approved as the only NSAID for pediatric use starting at 3 months of age, but not before 1.
  • At 2 months of age, the infant's renal function is still immature, making NSAID use particularly dangerous 3.

Why This Age Restriction Exists

  • Pre-existing renal disease or renal insufficiency represents a major contraindication to NSAID use, and young infants have inherently immature kidney function that places them at higher risk 3.
  • NSAIDs can cause acute renal failure, particularly in children with compromised kidney function or immature renal systems 3, 4.
  • Dehydration plays an important role in triggering renal damage with ibuprofen, and young infants are at higher risk of dehydration 1.

Additional Safety Concerns in Young Infants

  • NSAIDs are contraindicated when breastfeeding a neonate with jaundice because most NSAIDs displace bilirubin, potentially worsening hyperbilirubinemia 3.
  • The main risk to children taking NSAIDs is dosage errors resulting in overdose, which can cause significant morbidity and death—a risk that is magnified in very young infants where precise weight-based dosing is critical 3.
  • Ibuprofen should never be given to patients with diarrhea and vomiting, conditions that are common in young infants 1.

Safe Alternatives for a 2-Month-Old

  • Acetaminophen (paracetamol) is the appropriate antipyretic and analgesic for infants under 3 months of age 5.
  • One large randomized controlled trial showed ibuprofen and acetaminophen were equivalent in adverse event risk in older children, but this does not apply to infants under 3 months 3.

When Ibuprofen Becomes Appropriate

  • Short-term use of ibuprofen is considered safe only in infants older than 3 months of age having a body weight above 5-6 kg when special attention is given to hydration 2.
  • The recommended dose is 5-10 mg/kg based on body weight, administered 3-4 times daily, with a maximum total daily dose of 30-40 mg/kg 2.
  • Baseline renal function tests should be obtained before initiating NSAIDs in any child requiring chronic use 3.

Critical Clinical Pitfall

  • Never use ibuprofen in a 2-month-old infant under any circumstances—the risk of renal injury, bilirubin displacement, and dosing errors far outweighs any potential benefit 3, 1, 2.

References

Guideline

Contraindications for NSAID Use in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.